ArticleFrontiers in oncology2023
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma.
Ann W Silk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleFrontiers in oncology2023
Ann W Silk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.